loadpatents
Patent applications and USPTO patent grants for Cafri; Gal.The latest application filed is for "hla class ii-restricted t cell receptors against mutated ras".
Patent | Date |
---|---|
Hla Class Ii-restricted T Cell Receptors Against Mutated Ras App 20220204584 - Cafri; Gal ;   et al. | 2022-06-30 |
Hla Class I-restricted T Cell Receptors Against Mutated Ras App 20210079058 - Yoseph; Rami ;   et al. | 2021-03-18 |
Methods Of Enriching Cell Populations For Cancer-specific T Cells Using In Vitro Stimulation Of Memory T Cells App 20210052642 - Cafri; Gal ;   et al. | 2021-02-25 |
Cancer Immunization Platform App 20210030856 - Eisenbach; Rachel Lea ;   et al. | 2021-02-04 |
Methods Of Preparing An Isolated Population Of Dendritic Cells And Methods Of Treating Cancer Using Same App 20200017831 - Cafri; Gal ;   et al. | 2020-01-16 |
Hla Class Ii-restricted T Cell Receptors Against Mutated Ras App 20190085046 - Yoseph; Rami ;   et al. | 2019-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.